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The Work Package 4 of the ORAMED project, a collaborative project (2008–11) supported by the European Commission
within its seventh Framework Programme, is concerned with the optimisation of the extremity dosimetry of medical staff in
nuclear medicine. To evaluate the extremity doses and dose distributions across the hands of medical staff working in nuclear
medicine departments, an extensive measurement programme has been started in 32 nuclear medicine departments in Europe.
This was done using a standard protocol recording all relevant information for radiation exposure, i.e. radiation protection
devices and tools. This study shows the preliminary results obtained for this measurement campaign. For diagnostic purposes,
the two most-used radionuclides were considered: 99mTc and 18F. For therapeutic treatments, Zevalinw and DOTATOC (both
labelled with 90Y) were chosen. Large variations of doses were observed across the hands depending on different parameters.
Furthermore, this study highlights the importance of the positioning of the extremity dosemeter for a correct estimate of the
maximum skin doses.
INTRODUCTION
As a consequence of the definition that the dose limit
for the skin has to be applied to ‘the dose averaged
over any area of 1 cm2 regardless of the area
exposed’, it is advisable to measure the local skin
dose at the location with presumably the highest
exposure. This requirement is the central dilemma of
extremity dosimetry and causes severe practical diffi-
culties. In daily practice, in nuclear medicine, it is
often not known which part of the hand will receive
the highest dose. Moreover, the dose distribution over
the hand may vary during a single process as well as
when several people perform the same procedure(1).
To tackle, amongst other things, these problems, the
ORAMED project (a collaborative project supported
by the European Commission within its seventh
Framework Programme) was started at the beginning
of 2008. The Work Package 4 of this project aims at
optimising radiation protection of medical staff in
nuclear medicine. The goal of the present work was to
measure skin doses Hp (0.07) at different positions on
the hands for several nuclear medicine procedures
using the appropriate measuring tools. The procedures
were selected according to their frequency of use, the
delivered doses and the three types of radionuclides
commonly used in nuclear medicine, i.e. positron,
beta and gamma emitters.. For diagnostic purposes,
two radionuclides are considered: 18F is used for posi-
tron emission tomography (PET) examinations and
99mTc is used for planar and single photon emission
computed tomography (SPECT) examinations. The
two most frequently used therapeutic agents are 90Y-
labelled Zevalinw and DOTATOC. Other treatments
based on drugs labelled with other radionuclides (32P,
177Lu, etc.) were also registered, but the results will
not be reported in this paper.
MATERIALS AND METHODS
An extensive measurement programme is being per-
formed in 32 nuclear medicine departments distribu-
ted among hospitals in seven different countries
across Europe with a unified protocol, where all
relevant information for radiation exposure (i.e. radi-
ation protection devices and tools, dominant hand,
staff experience) were recorded. Using the same pro-
tocol, the measurements are harmonised and all
data can be compared and evaluated. The protocol
includes preparation and administration, indepen-
dently, both for diagnostic and therapeutic appli-
cations. The skin dose on the hands was measured
with high-sensitivity thermoluminescent dosemeters
(TLDs) specific for beta- and gamma-radiation.
Figure 1 shows their placement on gloves at 11
different positions for each hand.. Moreover, TLDs
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were welded in thin plastic bags to reduce the thick-
ness on top of the TLD and adequately measure the
quantity Hp(0.07).
An intercomparison between the participating lab-
oratories was performed at IRSN to assess and
compare the methods used for the calibration of the
dosemeters. The main goal of this intercomparison
was to establish a common basis for the measure-
ment campaign among all participants. Two differ-
ent reference irradiation fields were used: 137Cs and
85Kr, defined in compliance with the ISO 4037-1(2)
and 6980-1(3) standard. Standard TLDs
(LiF:Mg:Cu:P and LiF:Mg:Ti, up to 240 mg cm22),
used for gamma-ray measurements, were irradiated
with 137Cs and thin TLDs (8–10 mg cm22), used
for positron and beta pharmaceuticals(4), were irra-
diated with 85Kr. All participants reported results
within 10 % of the reference value (2 mSv).
RESULTS AND DISCUSSION
Preliminary results from the measurement campaign
are shown in Tables 1 and 2. At the moment, 115
workers from 32 nuclear medicine departments have
been monitored. The aim is that every worker is mon-
itored at least five times for the same diagnostic pro-
cedure. For this study, all measurements have been
considered even when the number is smaller than five
(for 50 % of the workers). To compare measurements
from different departments, for each procedure, the
dose equivalent to the hands Hp(0.07) was measured
and normalised to the respective manipulated
activity. In general, there is a large spread of results,
due to the influence of many factors, such as the type
of protections used and the experience of the workers.
The complete statistical analysis of the results is
under progress. The uncertainties associated to the
different values are not given for simplification of
reading the tables and figures.
The maximum normalised doses in Tables 1 and 2
correspond to the maximum values among all
workers and all measuring positions in the hands.
Mean and median dose values correspond to the
mean and median value at the position where the
maximum dose is most frequently found, usually
the index tip/nail and the thumb.
Normalised doses are higher for 18F than for
99mTc, as shown in Table 1. However, diagnostic pro-
cedures using 99mTc are more frequent than those
using 18F. Thus, the activities manipulated are
usually higher for 99mTc than for 18F. Comparing
Table 1 with Table 2, the doses obtained for diagnos-
tics procedures were found to remain much lower
than the values measured for therapeutic procedures
with 90Y. Usually preparation delivers higher doses
than the administration of the radiopharmaceutical.
Three main reasons contribute to this effect. First,
the activities manipulated for preparation are higher
than those manipulated for the administration of the
radiopharmaceutical. Second, some of the prep-
aration steps are performed with an unshielded
source, while the administration of the radiopharma-
ceutical to the patient is usually performed with a
shielded syringe. Finally, the time needed to prepare
a radiopharmaceutical is longer than the time
needed for administering it.
Mean normalised doses per position
The mean normalised doses found for each moni-
tored hand position are shown in Figures 2 and 3
for diagnostic and therapeutic procedures,
respectively.
From Figures 2 and 3, it is clearly seen that the
tips and nails of the fingers are the most exposed
areas in the hands. The two most exposed fingers are
the index and the thumb usually of the non-domi-
nant hand, followed by the middle and the ring. The
wrist position, even if used in some countries as
routine monitoring position(5), is the least exposed
position in the hand.
Position of the dosemeter for extremity monitoring
To comply with the definition of dose limit for the
skin, the recommended position for extremity moni-
toring is the position where the maximum dose can
be found.
Figure 1. TLDs positioning in the hands.
Table 1. Maximum, median and mean normalised doses for
the two radionuclides most commonly used for diagnostics.
Diagnostic radionuclides
A-99mTc P-99mTc A-18F P-18F
Maximum (mSv GBq21) 1.50 2.06 3.67 4.43
Median (mSv GBq21) 0.07 0.17 0.33 0.64
Mean (mSv GBq21) 0.07 0.32 0.71 0.77
‘A’ stands for administration and ‘P’ for preparation.
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Table 2. Maximum, median and mean normalised doses for 90Y Zevalinw and DOTATOC therapies.
Therapeutic radionuclides
A-90Y Zevalinw P-90Y Zevalinw A-90Y Dotatocw P-90Y Dotatocw
Maximum (mSv GBq21) 11.17 32.05 6.27 5.84
Median (mSv GBq21) 2.16 2.07 0.56 0.34
Mean (mSv GBq21) 2.46 3.52 0.65 1.65
‘A’ stands for administration and ‘P’ for preparation.
Figure 3. Mean normalised doses in each position of the hands for both preparation and administration for the two
therapies (Zevalinw and DOTATOC) considered.
Figure 2. Mean normalised doses in each position of the hands for the radionuclides used in diagnostics and for both
procedures—preparation and administration.
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Figures 4 and 5 show for each radionuclide and
for each procedure, the frequencies of the position
where the maximal dose was measured. The most
frequent positions correspond to the index tip/nail
and thumb of the non-dominant hand.
The impact of placing the routine monitoring dose-
meter at a different position than the one correspond-
ing to the maximal hand dose has been estimated by
calculating correction factors as ratios between the
index tip or maximum in the hand and the position
usually used for routine monitoring, i.e. the base of
the index or the ring finger, as shown in Figure 6.
The values used to compute the correction factors
are the mean dose values obtained by averaging
among all workers; so individual values can be even
much higher. Those factors vary from 1 to 7 depend-
ing on the radionuclide and the procedure. The correc-
tion factors with respect to the ring finger are usually
higher than those with respect to the base of the index
finger. Indeed, the index finger, specially the tip, is
usually one of the most-exposed fingers, in accordance
to what has already been observed in the literature(6).
CONCLUSIONS
Preliminary results show that large variations of skin
doses were observed across the hands, from 0.07 to
32.05 mSv GBq21, depending on the radionuclide
and procedure, but also on the worker and the radi-
ation-protection measures. Further analyses will be
done on these influences in the future.
The positioning of the dosemeter used in routine
monitoring strongly affects the estimates of the extre-
mity doses meaning that in some cases, the limit on
equivalent dose for the skin (0.5 Sv y21) could be
surpassed. For example, a worker manipulating an
annual realistic activity of 1500 GBq of 99mTc could
be receiving an annual dose of 150 mSv at the base
of the ring finger; in this case, the dose at the
maximum (factor 4 higher) will exceed the annual
limit of 500 mSv. From the available results, it can
be concluded that the position of the dosemeter on
the hand is important to obtain a correct estimate of
the extremity dose. Neither the wrist nor the ring
positions, ordinarily used as routine monitoring pos-
itions, are adequate for this purpose. A more correct
position will be the tip of the index finger on the
non-dominant hand. However, since this is difficult
to accomplish in daily practice, a ring dosemeter
placed on the base of the index finger of the non-
dominant hand might be a better alternative. In this
case, radiation protection officers must be aware that
the measured dose in such case will be around a
factor of 2.5 smaller than the maximum skin dose.
Figure 4. Frequencies of the position where the maximum dose was obtained for preparation and administration of 99mTc
and 18F. (The regions highlighted in grey and with capital letters correspond to the dominant hand, while that in white
correspond to the non-dominant hand. Positions where values are under 7 % are not labelled.)
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Figure 5. Frequencies of the position where the maximum dose was obtained, for 90Y Zevalinw and 90Y DOTATOC, for
preparation and administration. (The regions highlighted in grey and with capital letters correspond to the dominant
hand, and white to the non-dominant hand. Positions where values are under 7 % are not labelled.)
Figure 6. Correction factors computed for the non-dominant hand, i.e. usually the most-exposed hand. ‘Prep.’ stands for
preparation and ‘Adm.’ for administration.
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